Solid Biosciences (SLDB) Shareholder's Equity (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 374.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 374.13 Mn |
| Dec 31, 2025 | 180.01 Mn |
| Sep 30, 2025 | 217.95 Mn |
| Jun 30, 2025 | 258.29 Mn |
| Mar 31, 2025 | 294.46 Mn |
| Dec 31, 2024 | 137.25 Mn |
| Sep 30, 2024 | 167.02 Mn |
| Jun 30, 2024 | 193.25 Mn |
| Mar 31, 2024 | 210.72 Mn |
| Dec 31, 2023 | 126.48 Mn |
| Sep 30, 2023 | 144.36 Mn |
| Jun 30, 2023 | 163.73 Mn |
| Mar 31, 2023 | 183.79 Mn |
| Dec 31, 2022 | 211.67 Mn |
| Sep 30, 2022 | 143.28 Mn |
| Jun 30, 2022 | 162.24 Mn |
| Mar 31, 2022 | 185.51 Mn |
| Dec 31, 2021 | 208.21 Mn |
| Sep 30, 2021 | 223.36 Mn |
| Jun 30, 2021 | 237.94 Mn |
| Mar 31, 2021 | 253.00 Mn |
| Dec 31, 2020 | 132.09 Mn |
| Sep 30, 2020 | 22.23 Mn |
| Jun 30, 2020 | 40.71 Mn |
| Mar 31, 2020 | 56.46 Mn |
| Dec 31, 2019 | 80.05 Mn |
| Sep 30, 2019 | 108.53 Mn |
| Jun 30, 2019 | 76.50 Mn |
| Mar 31, 2019 | 99.11 Mn |
| Dec 31, 2018 | 125.18 Mn |
| Sep 30, 2018 | 145.07 Mn |
| Jun 30, 2018 | 162.29 Mn |
| Mar 31, 2018 | 178.95 Mn |
| Dec 31, 2017 | -59.26 Mn |